Global Negative Pressure Wound Therapy Market Size Worth USD 2.74 Billion at 5.1% CAGR; Rising Prevalence of Pressure Ulcers in Geriatric Population to Spur Growth: Fortune Business Insights(TM)

Pune, India, March 15, 2021 (GLOBE NEWSWIRE) — According to the report, Negative Pressure Wound Therapy market size is projected reach USD 2.74 Billion by 2026. Global Negative Pressure Wound Therapy market was USD 1.85 billion in 2018 and is anticipated to exhibit a CAGR of 5.1% during the forecast period set between 2019 to 2026.

As per the study, there is an increasing incidence of surgical site infections and chronic wounds amongst the masses worldwide. Thus, such factors would affect the market positively in the coming years.

Increasing Cases of Diabetic Foot Ulcer to Drive Growth

Nowadays, there exists a large patient pool across the world that are affected by chronic diseases, such as diabetes. Such conditions are further giving rise to diabetic foot ulcers. As per a published report by NHS, for instance, approximately 4.5 million people were affected by diabetes in the U.K. in 2017. Also, around 10.0% of that diabetic population developed foot ulcer at some point in their lives.

Additionally, as the geriatric population is rising, the cases of various conditions and diseases is also up surging. It is, in turn, causing reduced mobility amongst the affected populaces. These would contribute to the vacuum assisted closure devices market growth during the forecast period.

Request a Sample Copy of the Research Report:


The market houses several organizations of all sizes. They are at present, focusing on mergers and acquisitions, as well as bagging FDA approvals to gain maximum negative pressure wound therapy market share and strengthen their positions. Below are two of the key industry developments:

October 2019: 3M, a multinational conglomerate corporation based in the U.S., announced that it has completed the acquisition of Acelity, a privately held medical device company. 3M also acquired the latter’s KCI subsidiaries worth USD 6.7 billion. This acquisition would aid the former in enhancing its presence in surgical and advanced wound care.

October 2018: ConvaTec Group plc, an international medical products and technologies company, headquartered in the U.K., declared that it received FDA approval for Avelle NPWT system. It aids ConvaTec in entering the competitive U.S. NPWT market. Avelle can be used on a range of moderately-exuding to low wound types, consisting of surgically closed incisions, skin grafts, dehisced and sub-acute, traumatic, acute, and chronic wounds.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit:

North America to Grow Significantly Stoked by High Treatment Cost

In terms of region, the market is grouped into the Middle East and Africa, North America, Asia Pacific, Europe, and Latin America. Out of these, North America had acquired USD 738.1 million NPWT market revenue in 2018 and is expected to expand steadily in the forthcoming years. This growth is attributable to the high treatment cost and rising incidence of chronic wounds in the U.S. Europe would showcase a slow growth owing to the inadequate reimbursement policies in countries, namely, Italy, Spain, and France.

Asia Pacific, on the other hand, is anticipated to grow significantly by exhibiting a high CAGR. It is likely to occur because of the rising patient pool affected by chronic wounds, as well as an increasing prevalence of chronic diseases. The Middle East & Africa and Latin America would show a moderate CAGR on account of the unavailability of favorable reimbursement policies and expensive nature of treatments.

Quick Buy –  Negative Pressure Wound Therapy Market Research Report:

Key Companies Mentioned In Report:

  • Medela AG
  • KCI Licensing, Inc.
  • Smith & Nephew
  • Lohmann & Rauscher GmbH & Co. KG
  • ConvaTec Inc.
  • PAUL HARTMANN Asia-Pacific Ltd.
  • Cardinal Health
  • Talley Group Ltd.
  • Mölnlycke Health Care AB

Have Any Query? Ask Our Experts:

Global Negative Pressure Wound Therapy Market Segmentations:

By Device

  • Conventional NPWT
  • Single-use NPWT

By Indication

  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Burns & Trauma

By End User:

  • Hospitals
  • Clinics
  • Homecare Settings

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Get your Customized Research Report:

Have a Look at Related Reports:

Glaucoma Therapeutics Market Size , Share & COVID-19 Impact Analysis, By Drug Class (Beta Blockers, Prostaglandins Analogs, Alpha Adrenergic Agonists, Carbonic Anhydrase Inhibitors, Combination Drugs, and Others), By Disease Indication (Open Angle Glaucoma, Angle Closure Glaucoma, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Spinal Cord Stimulation Market Size , Share & COVID-19 Impact Analysis, By Product (Rechargeable and Non-rechargeable), By Disease Indication (Failed Back Surgery Syndrome (FBSS), Degenerative Disc Disease (DDD), Complex Regional Pain Syndrome (CRPS), Arachnoiditis, and Others) By End User (Hospitals, Ambulatory Surgery Centers, and Specialty Clinics), and Regional Forecast, 2020-2027

Cardiovascular Drugs Market Size , Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease, Arrhythmia, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2026

Ophthalmic Disease Therapeutics Market Size , Share and Industry Analysis By Disease Indication (Glaucoma, Retinal Diseases, Dry Eye Disease, Allergy & Infections), By Drug Class (Anti-inflammatory, Anti-infectives, Anti-VEGF, Anti-glaucoma), By Dosage Form (Solid, Liquid, Semi-solid), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Regional Forecast 2019-2026

Lung Cancer Therapeutics Market Size , Share and Industry Analysis By Therapy (Targeted, Therapy, Immunotherapy, Chemotherapy), By Cancer Type (Non-small cell lung cancer (NSCLC), Small cell lung cancer (SCLC)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecast 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: [email protected]
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release:

Primary Logo